Betopharm and Ascle Biotech Announce Strategic Collaboration to Advance NK Cell Applications in Cancer Prevention, Anti-Aging, and Aesthetic Medicine

SuZhouNovember 20, 2023/PR Newswire/ --November 20, 2023Porton Biologics Ltd. (hereinafter referred to as Porton Biologics) announced a strategic cooperation with Go Better Studio Accessibility Technology (SuZhou) Co., Ltd. (hereinafter referred to as Go Better Studio), to jointly promote the development and production of NK cells, advance innovation in the gene and cell therapy field, and accelerate the application of NK cells in cancer prevention, beauty, and anti-aging areas.

Porton Biologics Ltd. is committed to providing end-to-end gene and cell therapy CDMO services, covering areas such as plasmids, cell therapy, gene therapy, oncolytic viruses, nucleic acid therapy, and live bacterial therapies. It has successfully assisted clients in completing CMC and global regulatory submission services for multiple gene and cell therapy drugs. Go Better Studio Accessibility Technology (SuZhou) Co., Ltd. focuses on the research and production of breakthrough immunotherapy cell treatment products, primarily concentrating on NK/CAR-NK anti-tumor immune cell therapy drugs. The company has established a comprehensive R&D and manufacturing system for immune cell therapy, featuring three major technology platforms: universal CAR-NK, allogeneic NK/CAR-NK, and mRNA-LNP. According to the agreement, Porton Biologics will provide development, manufacturing, and regulatory submission services in China for Go Better Studio’s NK cell project, supporting its applications in cancer prevention, anti-aging, and aesthetic fields.

Dr. Hua Shun Li, founder and chairman of Go Better Studio Accessibility Technology (SuZhou) Co., Ltd., said: "CAR-NK cell therapy hasPotential. This therapy modifies NK cells through genetic engineering, enabling them to better recognize and kill tumor cells while reducing harm to normal cells. In the field of solid tumor treatment, CAR-NK cell therapy hasAdvantages。Moreover, NK cells in anti-aging,A single dose of 2 billion young and healthy cells can reduce circulating senescent cells by up to80%-100%^[1] , with sustained efficacy lasting from 3 months to 18 months. Go Better Studio Accessibility Technology (SuZhou) Co., Ltd. has deep expertise and technological advantages in the NK field, and we have developed the Ascle-NK platform to cultivate superior, highly potent NK cells. Meanwhile, Porton Biologics Ltd. has achieved remarkable success in the research, production, and project registration of gene and cell therapy drugs. I believe that with their extensive experience and specialized technology, Porton Biologics Ltd. can provide significant support for Go Better Studio Accessibility Technology (SuZhou) Co., Ltd. in promoting the application of NK cells in anti-aging, beauty, and cancer prevention.

Dr. Wang Yangzhou, CEO of Porton Biologics, stated: "We are very pleased to reach a strategic cooperation with Go Better Studio Accessibility Technology (SuZhou) Co., Ltd. Go Better Studio has a deep accumulation and advantages in the R&D pipeline, especially in the NK field. Porton Biologics has established an end-to-end gene and cell therapy CDMO platform, with excellent process development capabilities and sterile pharmaceutical production workshops, as well as high-quality GMP cell product manufacturing capabilities and experience, which can be customized according to customer needs. Meanwhile, Porton Biologics also possesses internationally advanced analytical method development technology and platforms, ensuring the quality and safety of future products, empowering and supporting Go Better Studio’s R&D and production projects with international production, testing, and release standards. We are highly looking forward to a close collaboration with Go Better Studio, combining our strengths to jointly promote the CMC and regulatory submission in China for NK cell projects. Through Porton Biologics’ CDMO platform, we will rapidly support Go Better Studio in making new progress in the field of NK cell anti-aging, beauty, and cancer prevention."

[1] Yousefzadeh, M. J., Flores, R. R., Zhu, Y., Schmiechen, Z. C., Brooks, R. W., Trussoni, C. E., Cui, Y., Angelini, L., Lee, K. A., McGowan, S. J., Burrack, A. L., Wang, D., Dong, Q., Lu, A., Sano, T., O'Kelly, R. D., McGuckian, C. A., Kato, J. I., Bank, M. P., Wade, E. A., … Niedernhofer, L. J. (2021). An aged immune system drives senescence and ageing of solid organs. Nature, 594(7861), 100–105. https://doi.org/10.1038/s41586-021-03547-7